3Shintani S, Kikuchi S, Hamaguchi H, et al. High serum lipprotein(a) levels are independent rish factor for cerbral infarction. Stroke,1993,24:967～969.
2Eckardstein AV, Schulte H, Cullen P, et al. Lipoprotein (a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol, 2001, 37:434-439.
3Assmann G, Schulte H, Eckardstein AV, et al. Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men. Am J Cardiology, 1996, 77:1179-1184.
4Shintani S, Kikuchi S, Hamaguchi H, et al. High serum lipoptotein(a) levels are an independent risk factor for cerebral infarction. Stroke, 1993, 24:965-969.
5Amemiya H, Arinami T, Kikuchi S, et al. Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease . Atherosclerosis, 1996, 123:181-191.
6Brazier L, Tiret L, Luc G, et al. Sequeence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein (a) levels and myocardial infarction. The ECTIM study. Atherosclerosis,1999, 144:323-333.
7Glader CA, Stegmayr B, Boman J, et al. Chlamydia pneumoniae antibodies and high lipoprotein (a) levels do not predict ischemic cerebral infarctions results from a nested case-control study in northern Sweden. Stroke, 1999,30:2013-2018.
8Kronenberg F, Kronenberg MF, Kiechl S, et al. Role of liphprotein(a) and apolipoprotein(a) phenotype in atherogenesis prospective results from the Bruneck study. Circulation, 1999, 14:1154-1160.
9Valenti K, Aveynier E, Leaute S, et al. Contribution of apolipoprotein(a) size , pentanucleotide TTTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein (a) plasma levels in a population of young European Caucasians. Atherosclerosis,1999, 147:17-24.
10Kalina A, Császár A, Füst G, et al. The association of serum lipoprotein (a) levels, apolipoprotein(a) size and (TTTTA)n polymorphism with coronary heart disease . Clin Chim Acta, 2001,309:45-51.
